Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Massachusetts - Page 4

Massachusetts

Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Vaccine

Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)

On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…

Read More Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)Continue

Moderna announced new supply agreement with Colombia for additional 10.8 million doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced new supply agreement with Colombia for additional 10.8 million doses of COVID-19 vaccine

On Feb. 8, 2022, Moderna announced a new supply agreement with the government of Colombia for 10.8 million…

Read More Moderna announced new supply agreement with Colombia for additional 10.8 million doses of COVID-19 vaccineContinue

CDC’s ACIP issued recommendation for use of Moderna COVID-19 vaccine in adults aged =18 years
Biotechnology | CDC | COVID-19 | Infectious Disease | Vaccine

CDC’s ACIP issued recommendation for use of Moderna COVID-19 vaccine in adults aged =18 years

On Feb. 4, 2022, the Advisory Committee on Immunization Practices (ACIP) issued a standard recommendation for use of…

Read More CDC’s ACIP issued recommendation for use of Moderna COVID-19 vaccine in adults aged =18 yearsContinue

Moderna received full U.S. FDA approval for COVID-19 vaccine Spikevax
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna received full U.S. FDA approval for COVID-19 vaccine Spikevax

On Jan. 31, 2022, Moderna announced the U.S. Food and Drug Administration (FDA)  had approved the Biologics License…

Read More Moderna received full U.S. FDA approval for COVID-19 vaccine SpikevaxContinue

Moderna announced first participant dosed in phase 2 study of Omicron-specific booster candidate and publication of data
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced first participant dosed in phase 2 study of Omicron-specific booster candidate and publication of data

On Jan. 26, 2022, Moderna announced that the first participant had been dosed in the Phase 2 study…

Read More Moderna announced first participant dosed in phase 2 study of Omicron-specific booster candidate and publication of dataContinue

Scientists regrow frogメs lost leg
Life Science History

Scientists regrow frogメs lost leg

On Jan. 26, 2022, scientists at Tufts and Harvard Universityメs Wyss Institute reported they were able to trigger…

Read More Scientists regrow frogメs lost legContinue

Moderna announced Switzerland exercised option to purchase seven million additional doses of COVID-19 booster vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced Switzerland exercised option to purchase seven million additional doses of COVID-19 booster vaccine

On Dec. 27, 2021, Moderna announced that the Swiss Federal Government had exercised its option to purchase an…

Read More Moderna announced Switzerland exercised option to purchase seven million additional doses of COVID-19 booster vaccineContinue

Moderna announced supply agreement with South Korea for additional 20 million doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with South Korea for additional 20 million doses of COVID-19 vaccine

On Dec. 27, 2021, Moderna announced a revised supply agreement with the government of South Korea for 20…

Read More Moderna announced supply agreement with South Korea for additional 20 million doses of COVID-19 vaccineContinue

Moderna announced preliminary booster data and updated strategy to address Omicron variant
Biotechnology | Infectious Disease | Vaccine

Moderna announced preliminary booster data and updated strategy to address Omicron variant

On Dec. 20, 2021, Moderna announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster…

Read More Moderna announced preliminary booster data and updated strategy to address Omicron variantContinue

Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia
Biotechnology | Infectious Disease | Vaccine

Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia

On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…

Read More Moderna and Australia announced collaboration to bring mRNA manufacturing to AustraliaContinue

Moderna announced additional 20 million doses of COVID-19 vaccine to COVAX for supply in 2021 and additional supply for 2022
Biotechnology | Infectious Disease | Vaccine

Moderna announced additional 20 million doses of COVID-19 vaccine to COVAX for supply in 2021 and additional supply for 2022

On Dec. 10, 2021, Moderna announced an amendment to its existing contract with Gavi, the Vaccine Alliance, to…

Read More Moderna announced additional 20 million doses of COVID-19 vaccine to COVAX for supply in 2021 and additional supply for 2022Continue

Moderna launched AI Academy in partnership with Carnegie Mellon University
Artificial Intelligence | Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna launched AI Academy in partnership with Carnegie Mellon University

On Dec. 9, 2021, Moderna announced the launch of its Artificial Intelligence Academy, an innovative initiative that will…

Read More Moderna launched AI Academy in partnership with Carnegie Mellon UniversityContinue

Resilience and Harvard University announced five-year R&D alliance to incubate new technologies
Life Science History | Vaccine

Resilience and Harvard University announced five-year R&D alliance to incubate new technologies

On Dec. 2, 2021, National Resilience and Harvard University announed they had established a five-year research and development…

Read More Resilience and Harvard University announced five-year R&D alliance to incubate new technologiesContinue

Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023

On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…

Read More Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023Continue

FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older

On Nov. 19, 2021, the U.S. Food and Drug Administration (FDA) announced that it had extended the emergency…

Read More FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and olderContinue

EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries
Biotechnology | COVID-19 | Infectious Disease | Vaccine

EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries

On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…

Read More EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countriesContinue

Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older

On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…

Read More Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and olderContinue

Moderna filed to expand the conditional Marketing Authorization for COVID-19 vaccine in the EU to include children ages 6-11 years
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna filed to expand the conditional Marketing Authorization for COVID-19 vaccine in the EU to include children ages 6-11 years

On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…

Read More Moderna filed to expand the conditional Marketing Authorization for COVID-19 vaccine in the EU to include children ages 6-11 yearsContinue

Moderna updated timing of U.S. Emergency Use Authorization of its COVID-19 vaccine for adolescents
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna updated timing of U.S. Emergency Use Authorization of its COVID-19 vaccine for adolescents

On Oct. 31, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had notified the Company…

Read More Moderna updated timing of U.S. Emergency Use Authorization of its COVID-19 vaccine for adolescentsContinue

Moderna announced MOU to supply up to 110 million doses of Its COVID-19 vaccine to the African Union
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced MOU to supply up to 110 million doses of Its COVID-19 vaccine to the African Union

On Oct. 26, 2021, Moderna announced a new Memorandum of Understanding (MoU) to make up to 110 million…

Read More Moderna announced MOU to supply up to 110 million doses of Its COVID-19 vaccine to the African UnionContinue

Moderna announced Swissmedic authorized booster dose of Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced Swissmedic authorized booster dose of Moderna’s COVID-19 vaccine

On Oct. 26, 2021, Moderna announced that Swissmedic had authorized a booster dose of Spikevax, the Company’s vaccine…

Read More Moderna announced Swissmedic authorized booster dose of Moderna’s COVID-19 vaccineContinue

Moderna announced positive top line data from phase 2/3 study of COVID-19 vaccine in children 6 to 11 years of age
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna announced positive top line data from phase 2/3 study of COVID-19 vaccine in children 6 to 11 years of age

On Oct. 25, 2021, Moderna announced positive interim data from the Phase 2/3 study, called the KidCOVE study,…

Read More Moderna announced positive top line data from phase 2/3 study of COVID-19 vaccine in children 6 to 11 years of ageContinue

Moderna announced EMA’s CHMP recommended booster dose of Moderna’s COVID-19 vaccine in the European Union
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Moderna announced EMA’s CHMP recommended booster dose of Moderna’s COVID-19 vaccine in the European Union

On Oct. 25, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…

Read More Moderna announced EMA’s CHMP recommended booster dose of Moderna’s COVID-19 vaccine in the European UnionContinue

Moderna announced FDA authorization of booster dose of  COVID-19 vaccine in the U.S.
Biotechnology | COVID-19 | FDA | Infectious Disease

Moderna announced FDA authorization of booster dose of COVID-19 vaccine in the U.S.

On Oct. 20, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had authorized for emergency…

Read More Moderna announced FDA authorization of booster dose of COVID-19 vaccine in the U.S.Continue

Moderna announced FDA Advisory Committee unanimously voted in support of EUA for booster dose of COVID-19 vaccine
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna announced FDA Advisory Committee unanimously voted in support of EUA for booster dose of COVID-19 vaccine

On Oct. 14, 2021, Moderna confirmed that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological…

Read More Moderna announced FDA Advisory Committee unanimously voted in support of EUA for booster dose of COVID-19 vaccineContinue

Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine

On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…

Read More Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccineContinue

Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year

On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…

Read More Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per yearContinue

Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched

On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…

Read More Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launchedContinue

Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older

On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…

Read More Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and olderContinue

Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Pharmaceutical | Vaccine

Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidate

On Sept. 28, 2021, Sanofi announced that it had terminated plans for its own mRNA-based COVID-19 vaccine given…

Read More Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidateContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 6 … 15 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search